Joining the dots - Atomo announcement regarding its commercial arrangements with Access Bio Inc.
From a recent news article on 12th Sept -
"There is a big shortage in the market right now across the board," said Ron Gutman, co-CEO of Intrivo, a testing manufacturer. "We have a lot more demand than we’ve ever seen before."
Intrivio is the technology and business partner of Access Bio, one of six companies with Food and Drug Administration authorization to sell home tests directly to consumers. . Intrivio/Access Bio expect to begin selling retail rapid tests in the coming weeks.
- Forums
- ASX - By Stock
- AT1
- Ann: Trading Halt
Ann: Trading Halt, page-9
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AT1 (ASX) to my watchlist
|
|||||
Last
2.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.89M |
Open | High | Low | Value | Volume |
2.7¢ | 2.8¢ | 2.5¢ | $3.866K | 140.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 472951 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 143054 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 472951 | 0.025 |
2 | 617050 | 0.024 |
3 | 893000 | 0.023 |
7 | 604373 | 0.022 |
4 | 432292 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 143054 | 2 |
0.029 | 452248 | 7 |
0.030 | 419488 | 7 |
0.031 | 196496 | 4 |
0.033 | 367586 | 3 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |